Schonfeld Strategic Advisors LLC Mustang Bio, Inc. Transaction History

Schonfeld Strategic Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.32 - $8.27 $832 - $21,502	-2,600 Reduced 15.12%	14,600 $5,000
Q3 2022 Nov 14, 2022	BUY	$0.46 - $7.2 $7,912 - $123,840	17,200 New	17,200 $8,000
Q4 2020 Feb 16, 2021	SELL	$2.66 - $4.18 $279,566 - $439,317	-105,100 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$3.01 - $3.88 $853,635 - $1.1 Million	-283,600 Reduced 72.96%	105,100 $0
Q2 2020 Aug 14, 2020	BUY	$2.33 - $4.6 $905,671 - $1.79 Million	388,700 New	388,700 $1.24 Million
Q4 2019 Feb 14, 2020	SELL	$2.57 - $4.08 $387,813 - $615,672	-150,900 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$2.74 - $4.65 $69,870 - $118,575	-25,500 Reduced 14.46%	150,900 $492,000
Q2 2019 Aug 14, 2019	BUY	$2.66 - $6.28 $469,224 - $1.11 Million	176,400 New	176,400 $650,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $20M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.